<DOC>
	<DOCNO>NCT01702337</DOCNO>
	<brief_summary>This study compare health economic impact bivalent HPV vaccine ( HPV-1 ) quadrivalent HPV vaccine ( HPV-2 ) .</brief_summary>
	<brief_title>Prevalence-based Health Economic Model Bivalent Versus Quadrivalent Human Papillomavirus ( HPV ) Vaccine</brief_title>
	<detailed_description>This study use prevalence-based model ( use efficacy data vaccine 's respective trial publish cost data Taiwan ) estimate difference lesion , genital wart , cervical cancer cost healthcare payer 's perspective prevent HPV-1 HPV-2 vaccine one year ( woman vaccinate ) . It also analyse cost societal perspective .</detailed_description>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Female subject vaccinate either HPV1 HPV2 vaccine Taiwan ( hypothetical group ) .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Gardasil</keyword>
	<keyword>Prevalence-model</keyword>
	<keyword>Cervarix</keyword>
	<keyword>economic</keyword>
	<keyword>health</keyword>
</DOC>